İçeriğe geç

Neonatoloji

Uygun Hemostaz (Kanamanın Durması)

Rekombinant Aktive Faktör VII (rFVIIa)

Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (opens new window)

Brady KM, Easley RB, Tobias JD.

Kaynak‎: Paediatr Anaesth 2006;16(10):1042-6.

İndeks‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (opens new window)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (opens new window)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Kaynak‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

İndeks‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (opens new window)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (opens new window)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Kaynak‎: Pediatrics 2002;110(1 Pt 1):169-71.

İndeks‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (opens new window)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (opens new window)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Kaynak‎: Paediatr Drugs 2017;19(1):53-8.

İndeks‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (opens new window)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (opens new window)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Kaynak‎: J Perinatol 2011;31(3):188-92.

İndeks‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (opens new window)

Use of recombinant factor VIIa in infants with severe coagulopathy. (opens new window)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Kaynak‎: J Perinatol 2004;24(5):310-1.

İndeks‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (opens new window)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (opens new window)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Kaynak‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

İndeks‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (opens new window)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (opens new window)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Kaynak‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

İndeks‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (opens new window)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (opens new window)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Kaynak‎: Paediatr Anaesth 2009;19(4):364-70.

İndeks‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (opens new window)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (opens new window)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Kaynak‎: Spine 2004;29(12):1384-7.

İndeks‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (opens new window)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (opens new window)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Kaynak‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

İndeks‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (opens new window)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (opens new window)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Kaynak‎: Pediatr Blood Cancer 2009;53(6):1074-8.

İndeks‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (opens new window)